This page includes the latest FDA filings for Pierre Fabre Medicament. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
|---|---|---|
| Glenmark Pharmaceuticals Inc., USA, Pierre Fabre Medicament, Forest Laboratories Ireland Limited, Frontida BioPharm, LLC | Prescription Medication | 2026-03-26 |
| Glenmark Pharmaceuticals Inc., USA, Pierre Fabre Medicament, Forest Laboratories Ireland Limited, Frontida BioPharm, LLC | Prescription Medication | 2026-03-11 |
| Pierre Fabre Pharmaceuticals, Inc., Pierre Fabre Medicament, Pierre Fabre Medicament Production | Prescription Medication | 2020-02-01 |
| Pierre Fabre Pharmaceuticals, Inc., Pierre Fabre Medicament, Pierre Fabre Medicament Production | Prescription Medication | 2019-10-11 |
| NCAGE Code | F6414 | PIERRE FABRE MEDICAMENT |
| CAGE Code | F6414 | PIERRE FABRE MEDICAMENT PIERRE FABRE PHARMACEUTICALS PIERRE FABRE PHARMACEUTICALS |